Synthesis of Mannich Bases by Two Different ...

1 downloads 0 Views 336KB Size Report
their Acetylcholine Esterase and Carbonic Anhydrase Inhibitory Activities ... According to IC50 or Ki values the compounds 6 in Series A with morpholine and ...
Send Orders for Reprints to [email protected] Letters in Drug Design & Discovery, 2017, 14, 000-000

1

RESEARCH ARTICLE

Synthesis of Mannich Bases by Two Different Methods and Evaluation of their Acetylcholine Esterase and Carbonic Anhydrase Inhibitory Activities Halise I. Gul1,*, Alkan Demirtas1, Gokbay Ucar1, Parham Taslimi2 and Ilhami Gulcin2,3 1

Ataturk University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Erzurum, Turkey; 2Ataturk University, Faculty of Science, Department of Chemistry, Erzurum, Turkey; 3King Saud University, College of Science, Department of Zoology, Riyadh, Saudi Arabia Background: Mannich bases are an important compounds in medicinal chemistry. They have wide range of biological activities including carbonic anhydrase (CA) inhibitory and acetylcholine esterase inhibitory (AChE) activities.

ARTICLE HISTORY

Objective: It was aimed to synthesize Mannich bases, 1-aryl-3-(morpholin-4-yl/piperidin-1-yl)-1propanone hydrochloride, by microwave irradiation and conventional heating methods to compare the methods in terms of reaction times and yields and to investigate their inhibitory effects on AChE enzyme and CA isoenzymes.

Received: July 02, 2016 Revised: October 10, 2016 Accepted: November 18, 2016

Method: Mannich bases were synthesized using conventional heating and microwave irradiation methods under different reaction conditions. Inhibitory effects of the compounds on CA isoenzymes and AChE were evaluated according to literature procedure.

DOI: 10.2174/15701808146661611281206 12

Results: IC50 and Ki values of the compounds were evaluated against hCA I, II and AChE. The compounds had more potent or equal Ki values with the references used. Conclusion: This study makes an important contribution to the Mannich base library in terms of synthetic strategy. According to IC50 or Ki values the compounds 6 in Series A with morpholine and and 15 in Series B with piperidine towards both hCA I and/or II isoenzymes and the compounds 4 in Series A and 11, 13, 14, 15, 16, and 18 in Series B towards AChE seemed the leader compounds of the study.

Keywords: Acetylcholine esterase, carbonic anhydrase, conventional heating, Mannich bases, microwave irradiation. INTRODUCTION Mannich bases are an important group of compounds in medicinal chemistry and they are synthesized by Mannich reaction [1]. Mannich bases have a wide range of biological activities such as carbonic anhydrase inhibitory [2-4], cytotoxic [5-8], anti-inflammatory [9] anticonvulsant [10] and acetylcholine esterase inhibitory [11] activities. The reported mechanisms of Mannich bases for their bioactivities are thiol alkylation [12-15], interaction with enzymes which are important for antioxidant mechanisms [6], inhibition of mitochondrial respiration [16, 17], inhibition of topoisomerase enzyme [18, 19] and the inhibition of tubulin polimerization [20]. Cholinesterases (ChE) are an enzyme family that catalyzes the hydrolysis of acetylcholine (ACh) into choline and acetic acid, an essential process for the restoration of cholinergic neurotransmission. There are two cholinesterase  

*Address correspondence to this author at the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University, Erzurum 25240, Turkey; Tel: +90 442 231 5203; Fax: +90 442 231 5201; E-mail: [email protected] 1570-1808/17 $58.00+.00

types: Acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8). AChE is known to be abundant in the muscle, brain, and erythrocyte membrane, whereas BChE has a higher activity in the liver, intestine, heart, kidney, and lung. They have similar molecular forms and active sites despite being products of different genes on the human chromosomes. Inhibition of hydrolyses of acetylcholine (ACh) and butrylcholine (BCh) by using cholinesterase inhibitors have been considered to increase the level of the ACh and BCh in synapses, which is a useful approach for the treatment of Alzheimer disease (AD). AD is a progressive, chronic, neurodegenerative disorder, characterized by decline in the memory and cognitive abilities. It is estimated that about 6% of the population worldwide aged over 65 is affected. The etiology of AD is still not full known, but the reduced level of acetylcholine and butrylcholine plays a significant role [21]. Although there are many on-going researches for the treatment of AD, only some drugs were approved by FDA such as Tacrine, Donepezil and Rivastigmin. So, there is a need for some new compounds which can be good candidates for the development of new drugs having superior properties. ©2017 Bentham Science Publishers

2 Letters in Drug Design & Discovery, 2017, Vol. 14, No. 5

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze a very simple but physiologically and biochemically essential reaction in all life kingdoms, followed by the hydration of carbon dioxide (CO2) to bicarbonate (HCO3-) and protons (H+), with a high efficiency. They are present either in eukaryotes or prokaryotes and are encoded by six distinct non-related gene families: alpha (α), beta (β), gamma (γ), delta (δ), zeta (ζ) and eta (η). All human CAs (hCAs) belong to the alpha (α)-class. Until now, sixteen isozymes have been recognized, among these; only twelve are catalytically active (CAs I–IV, CAs VA–VB, CAs VI–VII, CA IX and CAs XII–XIV), whereas, the CA-related proteins (CARPs) VIII, X and XI were formed without any catalytic activity. CA I, and II are cytosolic ones [22, 23]. In the last years, CA isozymes have become an interesting target for the design of inhibitors or activators with biomedical applications and different human diseases such as glaucoma, osteoporosis, neurological disorders, cancer, etc. Originally, CA inhibitors (CAIs) were clinically used mainly as anti-glaucoma diuretics and anti-epileptics, while the novel generation compounds are currently under clinical investigation as antiobesity or anti-tumour drugs and diagnostic tools [22, 24, 25]. However, none of the CAIs in clinical use showed selectivity for a specific isoenzyme. Thus, the development of isoenzyme-specific CAIs inhibitors would be extremely helpful to discover novel classes of drugs lacking of a range of undesired side effects. Synthesis of several chemical structures by microwave irradiation is quite common experimental method especially during the last decades. It has been reported that microwave irradiation method improves the yield of reaction, shortens the reaction time, and provides saving from energy [26] compared to the synthesis by conventional heating method [27-30]. For instance, 3-(3-bromophenyl)-1-{4,6-dimethoxy2-hydroxy-3-[(4-methylpiperazin-1-yl)methyl]phenyl}prop2-en-1-one was synthesized with the yield of 96.5 % in 10 minutes by microwave irradiation while it was synthesized with the yield of 61 % in 1.5 hours by conventional heating method [31]. Although chemical synthesis by microwave irradiation is quite common, there is a limited number of studies on the synthesis of Mannich bases by microwave irradiation [32]. The aims of this study were to determine the most suitable experimental method for the synthesis of some mono Mannich bases having the chemical structure of 1-aryl-3(morpholin-4-yl/piperidin-1-yl)-1-propanone hydrochloride in terms of reaction time and reaction yield by the comparison of the conventional heating method with the microwave irradiation method. Thus, to find out the most suitable method which can be applied for the synthesis of

Gul et al.

new Mannich bases with different chemical structures in further and to make a contribution to the library of Mannich bases with a limited number of studies in which microwave irradiation method applied wasavailable. The Second aim was to investigate the effects of the compounds synthesized on carbonic anhydrase and acetylcholine esterase enzymes, since these enzymes play an important role in the physiology and pathology of several diseases and some types of Mannich bases were reported with CA [2-4] and AChE [11, [21, 40] inhibitory activities. The data obtained may help to find out new drug candidate compound/s for the enzyme activities in question for further studies. MATERIALS AND METHODS Chemistry All the reactions were carried out in CEM Discover Microwave Synthesis Systems, Model 908010 (CEM Matthews, NC, USA). Melting points were determined using an Electrothermal 9100 (IA9100, Bibby Scientific Limited, UK) instrument and were uncorrected. The reactions were monitored by thin layer chromatography (TLC). Synthesis of 1-Aryl-3-(Morpholin-4-yl/Piperidin-1-yl)-1Propanone Hydrochlorides (1-18) by Conventional Heating Method in Glacial Acetic Acid A ketone compound, paraformaldehyde and suitable amine were taken in 1:1.2:1 mol ratios and heated in 10 ml of glacial acetic acid at 120 oC for several times. The reactions were monitored by TLC using CHCl3: MeOH (9:1 or 8:2) as a solvent system. Compounds were purified by crystallisation. Chemical structures of the compounds were confirmed by 1H NMR (See Supplementary File) and their reported melting points. Amine part was changed as morpholine in Fig. ((1) Series A (1-9)) and piperidine in Series B (10-18). Physical data of the compounds obtained by the conventional heating method are reported in Table 1 (See Supplementary File). Synthesis of 1-Aryl-3-(Piperidin-1-yl)-1-Propanone Hydrochlorides (10-18) by Conventional Heating Method in Ethanol at pH=5 A ketone compound, paraformaldehyde and suitable amine were taken in 1:1.2:1 mol ratios and heated in 10 mL of ethanol acidified with HCl (37%) at 100 oC for several times. The reactions were monitored by TLC using CHCl3: MeOH (9:1 or 8:2) as a solvent system. The compounds were purified by crystallisation. Chemical structures of the compounds were confirmed by 1H NMR (See Supplementary File). Amine part was piperidine (10-13, 15, 16, 17).

O Ar

O N

.HCl

Ar

N

.HCl

O A Series (1-9)

B Series (10-18)

Ar: Phenyl (1,10), 4-methylphenyl (2,11), 4-methoxyphenyl (3,12), 4-chlorophenyl (4,13), 4-hydroxyphenyl (5,14), 4-bromophenyl (6,15), 4-fluorophenyl (7,16), 2-thienyl (8,17), 2-furyl (9,18)

Fig. (1). Chemical structures of the compounds 1-18.

CA and AChE Inhibitory Effects of Mannich Bases

Table 1.

Letters in Drug Design & Discovery, 2017, Vol. 14, No. 5

3

Physical data of 1-aryl-3-(morpholin-4-yl/piperidin-1-yl)-1-propanone hydrochlorides by conventional heating method in acetic acide. Ketone

Paraformaldehyde

(mmol)

(mmol)

Amine.HCl (mmol)

Reaction Time (min)

Yield (%)

Crystallisation Solvent

C6H5

12.5

15

12.5

125

39

MeOH

2

4-CH3C6H 4

11.2

13.4

11.2

125

53

CHCl3

3

4-CH3OC6H 4

10

12

10

75

41

MeOH/CHCl3

4

4-ClC6H4

9.7

11.6

9.7

125

21

MeOH/CHCl3

5

4-HOC6H4

11

13.2

11

65

30

MeOH/CHCl3

6

4-BrC6H4

7.5

9

7.5

95

55

MeOH/CHCl3

7

4-FC6H4

10.9

13.1

10.9

175

67

MeOH/CHCl3

8

C4H3 S (2-yl)

11.9

14.3

11.9

145

38

MeOH/CHCl3

9

C4H3O (2-yl)

13.6

16.3

13.6

175

23

MeOH/CHCl3

10

C6H5

12.5

15

12.5

205

46

MeOH/Et2O

11

4-CH3C6H 4

11.2

13.4

11.2

505

34

MeOH/Et2O

12

4-CH3OC6H 4

10

12

10

475

59

MeOH/CHCl3

13

4-ClC6H4

9.7

11.6

9.7

560

23

MeOH

14

4-HOC6H4

11

13.2

11

180

45

MeOH

15

4-BrC6H4

7.5

9

7.5

255

6

MeOH/Et2O

16

4-FC6H4

10.9

13.1

10.9

440

26

MeOH/Et2O

17

C4H3 S (2-yl)

11.9

14.3

11.9

585

34

MeOH/Et2O

18

C4H3O (2-yl)

13.6

16.3

13.6

180

23

MeOH/Et2O

Compounds

Aryl

1

Physical data of the compounds obtained by the conventional heating method in the ethanol at pH=5 are presented in Table 3 (See Supplementary File). Synthesis of 1-Aryl-3-(Morpholin-4-yl/Piperidin-1-yl)-1Propanone Hydrochlorides (1-18) by Microwave Irradiation Method A ketone compound, paraformaldehyde and suitable amine were taken in 1:1.2:1 mol ratios and heated in 10 mL of glacial acetic acid at 120 oC at 70 Watt for series A and B for several times. The reactions were monitored by TLC using CHCl3: MeOH (9:1 or 8:2) as a solvent system. The compounds were purified by crystallisation. Chemical structures of the compounds were confirmed by 1H NMR (data were not present) and their reported melting points. Amine part was morpholine in Series A (1-9) and piperidine in Series B (10-18). Physical data of the compounds obtained by microwave irradiation method are reported in Table 2 (See Supplementary File). BIOLOGICAL ACTIVITY Carbonic anhydrase inhibition and cholinesterase inhibition assays were realised according to the procedures reported in the literatures [2, 4, 23, 33, 34], respectively.

RESULTS AND DISCUSSION Microwave irradiation method decreased the reaction time in both the series, except compound 5. The decrease in the reaction time by microwave irradiation was 1.5-25 times in series A with morpholine, and 3.2-14.6 times in series B with piperidine. The increase in the reaction yield by microwave irradiation was 1.3 times for compound 3, 1.9 times for compound 4, 1.1 times for compounds 9 and 18, 1.4 times for compound 13, and 3.5 times for compound 15. However, the conventional heating method showed 1.1-1.8 times higher yield for compounds 2 (1.2 times), 7 (1.5 times), 8 and 17 (1.1 times), 6 and 11 (1.7 times), 1 (1.8 times), 5 (1.3 times), 10 (2.1 times), 12 (11.8 times), and 16 (1.6 times) than the microwave irradiation method (Table 4). Synthesis of the compounds 10-13, 15-17 were also realised at pH 5 in the ethanol acidified with HCl (37%) instead of glacial acetic acid (Table 3). The reaction time and reaction yields for these compounds were also compared. When the reactions were realised in the acetic acid (Table 1), the reaction time decreased 1.3-3.9 times compared to the reactions with the acidic ethanol medium used for the compounds 10 (3.9 times), 11 (2.1 times), 12, 13, and 14 (1.3 times), and 15 (1.4 times). In other words, the reaction medium with acidic ethanol increased the reaction time 1.33.9 times compared to the one in which the reaction medium

4 Letters in Drug Design & Discovery, 2017, Vol. 14, No. 5

Table 2.

Gul et al.

Physical data of 1-aryl-3-amino (morpholin-4-yl/piperidin-1-yl)-1-propanone hydrochlorides by microwave irradiation method.

Compounds

Aryl

Ketone (mmol)

Para Formaldehyde (mmol)

Amine.HCl (mmol)

Reaction Time (min)

Yield (%)

Crystallisation Solvent

Melting Point (oC)

1

C6H5

12.5

15

12.5

10

22

MeOH

177-178

2

4-CH3C6H 4

11.2

13.4

11.2

5

45

MeOH

206-208

3

4-CH3OC6H 4

10

12

10

10

53

MeOH/CHCl3

211-213

4

4-ClC6H4

9.7

11.6

9.7

55

40

MeOH/CHCl3

211-214

5

4-HOC6H4

11

13.2

11

240

24

MeOH

217-219

6

4-BrC6H4

7.5

9

7.5

60

33

MeOH

215-218

7

4-FC6H4

10.9

13.1

10.9

120

46

MeOH

204-207

8

C4H3 S (2-yl)

11.9

14.3

11.9

80

36

MeOH

220-224

9

C4H3O (2-yl)

13.6

16.3

13.6

80

26

MeOH/CHCl3

207-208

10

C6H5

12.5

15

12.5

65

22

MeOH/Et2O

191-192

11

4-CH3C6H 4

11.2

13.4

11.2

45

20

MeOH/Et2O

177

12

4-CH3OC6H 4

10

12

10

60

5

MeOH/CHCl3

211-212

13

4-ClC6H4

9.7

11.6

9.7

65

32

MeOH

189

14

4-HOC6H4

11

13.2

11

20

45

MeOH

221

15

4-BrC6H4

7.5

9

7.5

60

21

MeOH/Et2O

201-202

16

4-FC6H4

10.9

13.1

10.9

60

16

MeOH/Et2O

189-190

17

C4H3 S (2-yl)

11.9

14.3

11.9

40

31

MeOH/Et2O

200-202

18

C4H3O (2-yl)

13.6

16.3

13.6

40

25

MeOH/Et2O

185-186

o

Reported Compounds (mp, C) [Reference] = 1 (178-179) [35], 2 (224) [36], 3(212-214) [37], 4 (208-209) [38], 5 (215-217) [39], 6 (208-09) [40], 7 (187) [41], 8 (194) [42], 9 (191192) [43], 10 (178-184) [44], 11(174-177) [45], 12 (nr), 13 (188-190) [45], 14 (187-188) [46], 15 (206-207) [36], 16 (166-169) [40], 17 (201-202) [47], 18 (185-186) [48].

Table 3.

Physical data for the compounds 10-18 for which conventional heating method in ethanol at pH=5 was applied.

Compounds

Aryl

Para

Ketone (mmol)

Formaldehyde (mmol)

Amine.HCl (mmol)

Reaction Time (min)

Yield (%)

Crystallisation Solvent

10

C6H5

12.5

15

12.5

805

17

MeOH

11

4-CH3C6H 4

11.2

13.4

11.2

1075

24

MeOH

12

4-CH3OC6H 4

10

12

10

620

29

MeOH

13

4-ClC6H4

9.7

11.6

9.7

750

22

MeOH

14

4-HOC6H4

15

4-BrC6H4

7.5

9

7.5

360

32

MeOH

16

4-FC6H4

10.9

13.1

10.9

590

17

MeOH

17

C4H3 S (2-yl)

11.9

14.3

11.9

455

23

MeOH

18

C4H3O (2-yl)

Not studied

was acetic acid (Table 1 and 3). That is why the acetic acid was found to be a better solvent system for the synthesis and used as the reaction solvent for the synthesis of the designed

Not studied

chemical structures in this study. Comparative results of the reaction yield and times for the studied compounds are presented in Table 4.

CA and AChE Inhibitory Effects of Mannich Bases

Table 4.

Letters in Drug Design & Discovery, 2017, Vol. 14, No. 5

5

Comparative table for the compounds 1-18 for which by conventional heating and microwave irradiation methods were applied. Reaction Time (min)

Compounds

Yield (%)

Conventional

Microwave

Conventional

Microwave

1

125

10

39

22

2

125

5

53

45

3

75

10

41

53

4

125

55

21

40

5

65

240

30

24

6

95

60

55

33

7

175

120

67

46

8

145

80

38

36

9

175

80

23

26

10

205

65

46

22

11

505

45

34

20

12

475

60

59

5

13

560

65

23

32

14

180

20

45

45

15

255

60

6

21

16

440

60

26

16

17

585

40

34

31

18

180

40

23

25

Inhibitory effects of the compounds on carbonic anhydrase isoenzymes hCA I and hCA II are presented in Table 5. IC50 values of the compounds were in the range of 57.22 - 97.27 nM in Series A with mopholine, while they were in the range of 57.75 - 85.41 nM in Series B with piperidine for hCA I isoenzyme. On the other hand, IC50 values of the compounds were in the range of 61.88 - 99.02 nM in Series A and 69.31-86.63 nM in Series B a for hCA II isoenzyme, as shown in Table 5. IC50 values of the reference compound Acetazolamide (AZA) for hCA I and II were 197.30 nM and 115.50 nM, respectively. It means that all the compounds were more effective than AZA for both hCA I and II isoenzymes, since the IC50 values of the compounds were lower than AZA’s. When the effect of substituent on the phenyl ring in Series A with morpholine, was considered by comparing the IC50 values of compounds 2-7 with compound 1, it was noticed that any substituent on the phenyl ring rather than hydrogen was helpful to increase the activity against hCA I by lowering the IC50 value of the compound compared to the IC50 value of hydrogen substituted compound 1. The presence of oxygen atom in compound 3 with methoxy substituent decreased the activity compared to 2 with methyl substituent on the phenyl ring but when the hydroxy group,

which has less strerical hinderence than methoxy substituent, was introduced to the chemical structure in compound 5, it showed similar activity to compound 2 for hCA I. When series B with piperidine was considered, the effect of the substituent on the phenyl ring was not constant for hCAI. Compound 15 with bromine and compound 16 with fluorine had lower IC50 values than 10, which is a nonsubstituted compound and this suggested the increased activity for hCA I. The replacement of the phenyl ring (10) to thiophene (17) or furan (18) decreased the activity by increasing the IC50 value toward hCA I. The most effective compounds for hCA I in terms of the IC50 value were bromine substituted compounds 6 and 15 from series A and B, respectively. Among the compounds having halogen at the para position of the phenyl ring , the order of effectiveness in terms of inhibiting hCA I isoenzyme was as follows: compound 15 (with bromine) > 16 (with fluorine) > 13 (with chlorine) in Series B. It means that the activity was not depending on the electronegativity of the halogen in Series B. Halogen (4, 6, 7) or methoxy (3) substitution increased the activity in series A with morpholine compared to 1 for hCA II. The replacement of the phenyl ring (1) by furan (9) decreased the activity while the replacement of phenyl ring

6 Letters in Drug Design & Discovery, 2017, Vol. 14, No. 5

Table 5.

Gul et al.

Carbonic anhydrase and acetylcholine esterase inhibitory activities of the compounds 1-18. IC50 (nM)

Compounds

KI (nM)

hCA I

r2

hCA II

r2

AChE

r2

hCA I

hCA II

AChE

1

97.27

0.9670

84.94

0.9524

23.89

0.9608

52.58±8.55

64.63±25.86

11.52±5.18

2

74.26

0.9421

89.11

0.9344

17.33

0.9888

60.95±13.51

105.32±35.21

7.36±3.44

3

85.46

0.9655

71.69

0.9655

11.75

0.9698

68.50±21.15

63.05±21.35

5.02±1.28

4

61.63

0.9736

74.97

0.9409

10.19

0.9831

53.07±17.12

85.51±27.67

2.92±0.94

5

75.71

0.9624

97.47

0.9527

18.24

0.9687

46.39±5.89

62.53±16.10

7.18±1.64

6

57.22

0.9884

61.88

0.9391

12.61

0.9913

42.24±7.03

55.85±14.58

6.56±1.92

7

85.24

0.9610

73.24

0.9495

18.19

0.9587

57.61±8.068

74.72±25.97

12.29±4.16

8

71.95

0.9755

84.01

0.9202

16.12

0.9687

67.20±14.53

83.38±36.22

5.35±1.33

9

83.86

0.9658

99.02

0.9485

30.13

0.9623

84.02±25.70

90.97±21.58

13.45±6.44

10

73.10

0.9523

79.66

0.9297

15.75

0.9776

71.53±31.50

95.03±46.27

9.67±3.93

11

85.41

0.9436

75.57

0.9085

13.86

0.9879

80.69±30.95

60.13±13.95

4.11±1.77

12

70.08

0.9727

73.72

0.9275

22.35

0.9601

67.06±20.57

77.96±27.36

10.09±3.84

13

74.31

0.9522

81.53

0.9401

11.18

0.9774

53.72±11.98

80.95±37.27

4.53±1.63

14

75.76

0.9810

77.01

0.9323

14.75

0.9807

76.32±20.72

66.06±20.50

6.65±2.11

15

57.75

0.9905

69.31

0.9181

17.76

0.9858

54.98±13.70

78.06±26.45

6.31±2.09

16

69.22

0.9928

85.56

0.9551

16.49

0.9774

51.03±9.45

85.10±25.73

5.01±2.22

17

78.75

0.9604

83.49

0.9469

15.01

0.9850

98.73±28.22

81.18±19.66

8.09±2.02

18

76.07

0.9658

86.63

0.9615

21.66

0.9797

56.67±13.21

78.62±15.62

6.88±3.04

AZA*

197.30

0.9889

115.50

0.9719

-

-

183.39±19.71

104.60±27.60

-

TAC**

-

-

-

-

43.31

0.9948

-

-

23.29±4.07

*Acetazolamide (AZA) was used as a standard inhibitor for all hCA I-II **Tacrine (TAC) was used as a standard inhibitor for AChE enzyme.

by thiophene did not affect the activity for hCA II. The replacement of hydrogen in 1 by bromine (15), hydroxy (14), methoxy (12), and methyl (11) increased the activity for hCA II in Series B. Among the aromatic rings, phenyl was the best in terms of the IC50 values in both the series. Bromine substituted compounds 6 and 15 were the most effective ones for hCA II as well as in the case of hCA I. When the Ki values were considered, they were in the range of 42.24±7.03 and 84.02±25.70 nM in series A and 51.03±9.45 and 98.73±28.22 nM in series B, while the reference compound AZA had the Ki value of 183.39±19.71 nM for hCA I. This suggests that all the compounds (1-18) with lower Ki values than AZA’s were better inhibitor compared to the reference drug AZA, as shown in Table 5. The most potent compounds for hCA I were 6 (with bromime) in series A, and the compounds which have the similar Ki values in series B, 13 ( with chlorine), 15 (with bromine), and 16 (with fluorine) in terms of the Ki value . On the other hand, the Ki values of the compounds were in the range of 55.85±14.58 and 105.32 ±35.21 nM in series A and 60.13±13.95 and 95.03±46.27 nM in series B for hCA II. All the compounds 1-18, except 2 having the similar Ki

value with AZA, had more potent activity than AZA for hCA II. The most potent compounds for hCA II in terms of the Ki value was bromine substituted compound 6 in Series A and methyl substituted compound 11 in Series B. When the acetylcholine esterase inhibition effects of the compounds were considered, the IC50 values of compounds 1-9 in Series A with morpholine were in the range of 10.19 and 30.13 nM while they were in the range of 11.18 and 22.35 nM for compounds 10-18 in Series B with piperidine, as shown in Table 5. The most effective compounds for acetylcholine esterase inhibition were 4 and 13 having chlorine on the pheny ring in both the series A and B, respectively in terms of the IC50 values. Substitution on the phenyl ring other than hydrogen was a useful modification to increase AChE inhibitory activity in series A for compounds 2-7.The replacement of the phenyl ring 1 by thiophene 8 increased the AChE inhibition activity but the replacement of the phenyl ring 1 to furan 9 decreased the activity in Series A. Different substituent rather than hydrogen on the phenyl ring increased the activity slightly for compounds 11 (with

CA and AChE Inhibitory Effects of Mannich Bases

methyl), 13 (with chlorine), and 14 (with hydroxy) in Series B. The replacement of the phenyl ring 1 by thiophene 8 increased the AChE inhibitory activity (2.2 times) while the replacement of the phenyl ring 1 to furan 9 decreased slightly the activity. All the compounds studied 1-18 were 1.4 - 4.3 times more effective than the reference drug Tacrine (TAC) for the inhibition of AChE in terms of the IC50 Values. When the Ki values of the compounds were considered for AChE, they were in the range of 2.92±0.94 and 13.45±6.44 nM in series A while in the range of 4.11±1.77 and 10.09±3.84 nM in series B. The Ki value of the reference drug TAC was 23.29±4.07 nM. In terms of the AChE inhibition effect, the most effective compounds were compound 4 in series A and compounds 11, 13, 14, 15, 16, and 18 in series B in terms of the Ki values. As conclusion, this study makes an important contribution to the Mannich base library in terms of the synthetic strategy. Acetic acid was found to be a better solvent than ethanol. Microwave irradiation method made a clear improvement in the reaction times. In terms of the reaction yield, there was no best method since the yields differed depending on the compounds synthesized. It follows from the study that compounds 6 and 15 in Series A and B for both hCA I and II isoenzymes in terms of the IC50 or Ki values, and compounds 4 in Series A along with 11, 13, 14, 15, 16, and 18 in Series B in terms of the Ki values for AChE were examined. The leading compounds for in terms of both the IC50 and the Ki values, seems to be chlorine substituted compound 4 in series A and the methyl substituted compound 11 in series B.

Letters in Drug Design & Discovery, 2017, Vol. 14, No. 5 [6] [7]

[8] [9] [10]

[11]

[12]

[13]

[14] [15]

[16]

CONFLICT OF INTEREST The authors confirm that this article content has no conflict of interest. ACKNOWLEDGEMENTS This research work was supported by Ataturk University Research Found, Erzurum, Turkey (Project No: 2010/166, 2012/74, 2012/75).

[17]

[18] [19]

REFERENCES [1] [2]

[3]

[4]

[5]

Roman, G. Mannich bases in medicinal chemistry and drug design. Eur. J. Med. Chem., 2015, 89, 743-816. Yamali, C.,;Tugrak, M.; Gul, H. I.; Tanc, M.; Supuran, C. T. The inhibitory effects of phenolic Mannich bases on carbonic anhydrase I and II isoenzymes. J. Enzyme Inhib. Med. Chem. 2016, 31, 16781681. Bilginer, S.; Unluer, E.; Gul, H. I.; Mete, E.; et al. Carbonic anhydrase inhibitors. Phenols incorporating 2- or 3-pyridylethenylcarbonyl and tertiary amine moieties strongly inhibit Saccharomyces cerevisiae beta-carbonic anhydrase. J. Enzyme Inhib. Med. Chem., 2014, 29, 495-499. Gul, H. I.; Yamali, C.; Yasa, A. T.; Unluer, E.; et al. Carbonic anhydrase inhibition and cytotoxicity studies of Mannich base derivatives of thymol. J. Enzyme Inhib. Med. Chem., 2016, 31, 1375-1380. Gul, H. I.; Das, U.; Pandit, B.; Li, P. K. Evaluation of the cytotoxicity of some mono-mannich bases and their corresponding azine derivatives against androgen-independent prostate cancer cells. Arzneimittelforschung 2006, 56, 850-854.

[20] [21]

[22] [23]

[24]

[25]

7

Gul, H. I.; Gul, M.; Erciyas, E.; Toxicity of some bis Mannich bases and corresponding piperidinols in the brine shrimp (Artemia salina) bioassay. J. Appl. Toxicol., 2003, 23, 53-57. Gul, H. I.; Yerdelen, K. O.; Das, U.; Gul, M.; et al. Synthesis and cytotoxicity of novel 3-aryl-1-(3'-dibenzylaminomethyl-4'hydroxyphenyl)-propenones and related compounds. Chem. Pharm. Bull., 2008, 56, 1675-1681. Gul, M.; Mete, E.; Atalay, M.; Arik, M.; Gul, H. I. Cytotoxicity of 1-aryl-3-buthylamino-1-propanone hydrochlorides against Jurkat and L6 cells. Arzneimittelforschung 2009, 59, 364-369. Suleyman, H.; Gul, H. I.; Gul, M.; Alkan, M.; Gocer, F. Antiinflammatory activity of bis(3-aryl-3-oxo-propyl)methylamine hydrochloride in rat. Biol. Pharm. Bull., 2007, 30, 63-67. Gul, H. I.; Calis, U.; Vepsalainen, J. Synthesis and evaluation of anticonvulsant activities of some bis Mannich bases and corresponding piperidinols. Arzneimittelforschung 2002, 52, 863869. Liu, H.; Huang, X.; Lou, D.; Liu, X.; Liu, W.; Wang, Q. Synthesis and acetylcholinesterase inhibitory activity of Mannich base derivatives flavokawain B. Bioorg. Med. Chem Lett, 2014, 24, 4749-4753 Gul, M.; Atalay, M.; Gul, H. I.; Nakao, C.; et al. The effects of some Mannich bases on heat shock proteins HSC70 and GRP75, and thioredoxin and glutaredoxin levels in Jurkat cells. Toxicol. In Vitro, 2005, 19, 573-580. Gul, M.; Gul, H. I.; Das, U.; Hanninen, O. Biological evaluation and structure-activity relationships of bis-(3-aryl-3-oxo-propyl)methylamine hydrochlorides and 4-aryl-3-arylcarbonyl-1-methyl-4piperidinol hydrochlorides as potential cytotoxic agents and their alkylating ability towards cellular glutathione in human leukemic T cells. Arzneimittelforschung, 2005, 55, 332-337. Gul, M.; Gul, H. I.; Hanninen, O. Effects of Mannich bases on cellular glutathione and related enzymes of Jurkat cells in culture conditions. Toxicol. In Vitro, 2002, 16, 107-112. Gul, M.; Gul, H. I.; Vepsalainen, J.; Erciyas, E.; Hanninen, O. Effect of acetophenone derived Mannich bases on cellular glutathione level in Jurkat cells. A possible mechanism of action. Arzneimittelforschung, 2001, 51, 679-682. Kucukoglu, K.; Gul, H. I.; Cetin-Atalay, R.; Baratli, Y.; et al. Synthesis of new N,N'-bis[1-aryl-3-(piperidine-1yl)propylidene]hydrazine dihydrochlorides and evaluation of their cytotoxicity against human hepatoma and breast cancer cells. J. Enzyme Inhib. Med. Chem., 2014, 29, 420-426. Kucukoglu, K.; Gul, M.; Atalay, M.; Mete, E.; et al. Synthesis of some Mannich bases with dimethylamine and their hydrazones and evaluation of their cytotoxicity against Jurkat cells. Arzneimittelforschung, 2011, 61, 366-371. Canturk, P.; Kucukoglu, K.; Topcu, Z.; Gul, M.; Gul, H. I. Effect of some bis Mannich bases and corresponding piperidinols on DNA topoisomerase I. Arzneimittelforschung, 2008, 58, 686-691. Mete, E.; Gul, H. I.; Canturk, P.; Topcu, Z.; et al. Biological activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols on PC-3 cells and DNA topoisomerase I enzyme. Z Naturforsch C, 2010, 65, 647652. Das, U.; Gul, H. I.; Alcorn, J.; Shrivastav, A.; et al. Cytotoxic 5aryl-1-(4-nitrophenyl)-3-oxo-1,4-pentadienes mounted on alicyclic scaffolds. Eur. J. Med. Chem., 2006, 41, 577-585. Liu, H. R.; Liu, X. J.; Fan, H. Q.; Tang, J. J.; et al. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors. Bioorg. Med. Chem., 2014, 22, 6124-6133. Supuran, C. T. How many carbonic anhydrase inhibition mechanisms exist? J. Enzyme Inhib. Med. Chem., 2016, 31, 345360. Gul, H. I.; Tugrak, M.; Sakagami, H.; Taslimi, P.; et al. Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides. J. Enzyme Inhib. Med. Chem., 2016, 31, 1619-1624. Tanc, M.; Carta, F.; Scozzafava, A.; Supuran, C. T. 6-Substituted 1,2-benzoxathiine-2,2-dioxides are isoform-selective inhibitors of human carbonic anhydrases IX, XII and VA. Org. Biomol. Chem., 2015, 13, 77-80. Grandane, A.; Tanc, M.; Di Cesare Mannelli, L.; Carta, F.; et al., 6Substituted sulfocoumarins are selective carbonic anhdydrase IX

8 Letters in Drug Design & Discovery, 2017, Vol. 14, No. 5

[26]

[27]

[28]

[29]

[30] [31] [32] [33]

[34]

[35]

and XII inhibitors with significant cytotoxicity against colorectal cancer cells. J. Med. Chem., 2015, 58, 3975-3983. Kabalka, G. W.; Zhou, Li-Li; Wang, L.; Pagni, R.M. A microwaveenhanced, solventless Mannich condensation of terminal alkynes and secondary amines with para-formaldehyde on cuprous iodide doped alumina. Tetrahedron, 2006, 62, 857-897. Yashumati R.; Bhardwaj, M. C.; Pareek, A.; Dharma, K. Comparative study of the synthesis of 7-hydroxy-4-methyl coumarin Mannich bases by conventional and microwave method. Intern. Res. J. Pure Appl. Chem., 2013, 3, 250-256. Arora, R.; Gill, N. S.; Singh, N.; Rana, A.C. Microwave irradiation versus conventional method:Synthesis of some novel 2-substituted benzimidazole derivatives using mannich bases. Intern. J. Chem. Res., 2014, 6, 1110. Algul, O.; Meric, A.; Polat, S.; Yuksek, N. D.; Serin, M.S. Comparative studies on conventional and microwave-assisted synthesis of a series of 2,4-di and 2,3,4-trisubstituted benzimidazo[1,2-a] pyrimidines and their antimicrobial activities. Cent. Eur. J. Chem., 2009, 337-342. Vasanti, S.; Suman, M.; Priyanka, H. Comparative study of conventional and microwave assisted synthesis of N-acyl heterocycles. J. Pharm. Res. 2009, 2, 455-457. Dong, X.; Liu, T; Chen, J.; Ying, H.; Hu, Y.; Microwave-assisted Mannich reaction of 2-hydroxy-chalcones. Synth. Commun., 2009, 39, 733-742. Lehmann, F.; Pilotti, A.; Luthman, K. Efficient large scale microwave assisted Mannich reactions using substituted acetophenones. Mol. Divers., 2003, 7, 145-152. Gul, H. I.; Kucukoglu, K.; Yamali, C.; Bilginer, S.; et al. Synthesis of 4-(2-substituted hydrazinyl)benzenesulfonamides and their carbonic anhydrase inhibitory effects. J. Enzyme Inhib. Med. Chem., 2016, 31, 568-573. Ozgun, D. O.; Yamali, C.; Gul, H. I.; Taslimi, P.; et al. Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. J. Enzyme Inhib. Med. Chem., 2016, 31, 1498-1501. Pohland, A.; Sullivan, H. R. Reaction of Grignard reagents with βamino nitriles. J. Am .Chem Soc., 1955, 77, 2817-2818.

Gul et al. [36] [37]

[38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48]

Denton, J. J.; Turner, R. J.; Neier, W. B.; et al. Antispasmodics. I. Substituted β-amino ketones. J. Am. Chem. Soc.,1949, 71, 20482050. Moriarty, R. M.; Prakash, O.; Thachet, C.T.; Musallam, H. A. Synthesis of α-hydroxydimethylacetals from nitrogen heterocyclic ketones using hypervalent iodine oxidation. Heterocycles, 1985, 23, 639. Adamson, D. W., Billinghurst, J. W. Aminoalkyl tertiary carbinols and derived products. III. 3-Tertiary-amino-1-aryl-1-(2-pyridyl)-1propanols and-1-propenes. J. Chem. Soc. 1950, 6, 1039-1045. Italia, S. A. F. N-Morpholyl Substituted Ketones with Fungicidal Action and a Process for production thereof. L. Patent, 810497, 1959. Kuchař, M.; Brunová, B.; Grimová, J.; Vaněček, S.; Holubek, J. Synthesis of cyclohexylaliphatic acids and their pharmacological properties. Collect. Czech. Chem. Commun. 1986, 51, 2896-2908. Pathak, V. N.; Singh, R. P. Studies in fluorinated Mannich bases. Part 2: Synthesis and biological activity of some new 3alkylaminopropiophenones. Pharmazie, 1980, 35, 434. Harradence, R. H.; Lions, F. Use of morpholine for the production of "Mannich" bases. J. Proc. Roy. Soc. New South Wales, 1939, 72. Angeloni, A. S.; Bellotti, A.; Giovanni, P.;Stereospecitic inversion of some 2-furyl β-dialkylaminoethyl ketoximes. Gazz. Chim. Ital., 1960, 1616-1628. Albrecht, H. A. 3-Amino-2-aminomethyl-1-phenyl-1-propanols. U.S. Patent, 3058987, 1962. Kuchar, M.; Brunova, B.; Grimova, J.; Vanecek, S.; Holubek, J. Synthesis of cyclohexyl aliphatic acids and their pharmacological properties. Collect. Czech. Chem. Commun., 1986, 51, 2896-2908. Gautier, J. A. Miocque, M.; Quan, D.Q. Mannich reaction on phydroxyacetophenone. Compt. Rend. 1964, 258, 3731-3734. Blicke, F. F.; Burckhalter, J. H. Preparation of β-keto amines by the Mannich reaction. J. Am .Chem Soc., 1942, 64, 451-454. Levy, G. A.; Nisbet, H. B. Heterocyclic ketones. II. β-Amino ketones containing thiophene, thiazole and furan nuclei and their behavior toward phenylhydrazine. J. Am .Chem Soc., 1938, 10531056.